IndraLab

Statements


USP18 decreases the amount of IFITM1. 1 / 1
| 1

reach
"We demonstrated that USP18 deficient cells have increased expression of IFIT1, IFIT2, IFIT3, IFITM1, IFITM2, CXCL9, CXCL10, ISG15, and MX2 after treatment with exogenous IFN‐β."